1. Li, Jin-Tao, Yin, Miao, Wang, Di, Su, Dan, Lei, Qun-Ying. 2020. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma. In Nature cell biology, 22, 167-174. doi:10.1038/s41556-019-0455-6. https://pubmed.ncbi.nlm.nih.gov/32029896/
2. Han, Li, Dong, Lei, Leung, Keith, Chen, Jianjun, Deng, Xiaolan. . METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. In Cell stem cell, 30, 52-68.e13. doi:10.1016/j.stem.2022.12.006. https://pubmed.ncbi.nlm.nih.gov/36608679/
3. Wang, Yazhuo, Zhao, Ning, Meng, Yujiao, Li, Ping, Wang, Yan. 2024. Bcat2-Mediated Branched-Chain Amino Acid Catabolism Is Linked to the Aggravated Inflammation in Obese with Psoriasis Mice. In Molecular nutrition & food research, 68, e2300720. doi:10.1002/mnfr.202300720. https://pubmed.ncbi.nlm.nih.gov/38581348/
4. Vargas-Morales, Juan M, Guizar-Heredia, Rocio, Méndez-García, Ana L, Guevara-Cruz, Martha, Noriega, Lilia G. 2021. Association of BCAT2 and BCKDH polymorphisms with clinical, anthropometric and biochemical parameters in young adults. In Nutrition, metabolism, and cardiovascular diseases : NMCD, 31, 3210-3218. doi:10.1016/j.numecd.2021.07.011. https://pubmed.ncbi.nlm.nih.gov/34511290/
5. Dong, Baijun, Xu, Jun-Yu, Huang, Yuqi, Tan, Minjia, Qin, Jun. 2024. Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers. In Nature cancer, 5, 1427-1447. doi:10.1038/s43018-024-00820-2. https://pubmed.ncbi.nlm.nih.gov/39242942/
6. González-Salazar, Luis E, Granados-Portillo, Omar, Medina-Vera, Isabel, Tovar, Armando R, Guevara-Cruz, Martha. 2021. Effect of the BCAT2 polymorphism (rs11548193) on plasma branched-chain amino acid concentrations after dietary intervention in subjects with obesity and insulin resistance. In The British journal of nutrition, 128, 43-54. doi:10.1017/S0007114521002920. https://pubmed.ncbi.nlm.nih.gov/34340727/
7. Cao, Qixuan, Fan, Jie, Zou, Jian, Wang, Wei. 2024. Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulation. In Scientific reports, 14, 23371. doi:10.1038/s41598-024-74441-1. https://pubmed.ncbi.nlm.nih.gov/39375392/